Cook Pharmica , the contract biomanufacturing arm of Cook Medical, has appointed two vice presidents to its leadership.
Connie Degen has been named vice president of operations and Tedd Green vice president of business operations and chief financial officer (CFO).
Degen has been assuming the role of director of operations until that.
Prior to this, Degen quality director at Baxter Pharmaceutical Solutions.
With her new position, she will is responsible for directing and overseeing manufacturing activities.
Green joined Cook Pharmica two years ago after serving as a senior business analyst for Eli Lilly where he was responsible for providing general business support to Lilly's business-to-business operations.
In his new dual role, Green will be responsible for overseeing the fiscal, human resource, project management, business development and marketing programmes, policies and services.
Cook Pharmica specialises in manufacturing mammalian cell culture-based pharmaceuticals for pre-clinical through to commercial use.
Another Biopharmaceutical contract manufacturer, Cytovance, has announced it is expanding its sales and business development team.
The Oklahoma-based company last week hired Michael Faughnan to lead the team to meet growing demand for the company's unique services portfolio.
Faughnan is responsible for leading sales and business development efforts in western North America, including introducing key prospects to Cytovance's comprehensive range of process development and cGMP manufacturing services, as well as the company's portfolio of technical and strategic support services.
Before joining the Cytovance management team, Faughnan spent five years at Irvine Scientific in California as territory manager, where he was managing accounts for industrial and academic cell culture media and serum sales.
Meanwhile , BioStorage Technologies (BST) , which specialises in biomaterials storage, sample management and cold chain logistics, has hired James Saponaro as executive vice president.
In this new role, Saponaro - a long-time Cardinal Health executive - will overoversee the company's sales and marketing, operations, information technology and business development functions.
"Jim's experience in delivering on aggressive strategic plans and leading profitable, high-growth operations for various healthcare and life science organisations is a tremendous addition to the strong BioStorage Technologies team," said John Mills, BST's CEO.
Clinical research organisation PRA International has also made a senior management change recently, naming Linda Baddour executive vice president and CFO.
Baddour replaces Matt Bond, who resigned to pursue other opportunities.
She was previously CFO at Pharmaceutical Product Development (PPD).
The announcement comes just a month after the PRA named both a new president and a CEO.
The company appointed Terrance Bieker as CEO after he filled the position as an interim since December, and named Colin Shannon - who also used to work for PPD - president and chief operating officer.
In other news, contract manufacturer Draxis Pharma has appointed Bruce DeChambre as vice president of commercial and business development.
DeChambre will be in charge of identifying prospective customers and developing new business opportunities within the pharma sector while maintaining quality services to its existing clients.
DeChambre was a pharmaceutical industry consultant to investment firms and healthcare advertising agencies, and previously worked SAB-Pharma - which was recently acquired by Novartis - and Cardinal Health.
Draxis operates a current good manufacturing practice (cGMP) compliant facility in Quebec where it produces a broad range of dosage forms including injectable, oral and topical, sterile and non-sterile products, as well as sterile lyophilized injectable products in vials.
Finally, MDS Pharma Services , has named Howard Moody vice president of information technology (IT).
In his new role, Moody will be responsible for implementing effective IT applications to improve processes and fuel business growth in the company.
"As a leading contract research organisation, our business relies upon having innovative IT applications to meet our customers' needs on a global scale," said David Spaight, the company's president.
Before joining MDS, Moody was chief information officer at Medifacts International, a CRO based in Maryland, where he was responsible for global IT.
He also spent five years at Covance as chief information officer and senior vice-president.